LIGAND PHARMACEUTICALS INC - 53220K207
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Benchmark Capital Advisors | History | Reduced | 20,800 | 1,399 | 0.97% | 0.91% | 1 | -4,200 | -16.8% | Q1 2014 | Apr 16, 2014 |
| BAKER BROS. ADVISORS LP | History | Closed out | 0 | 0 | — | 0.05% | — | -73,400 | -100.0% | Q1 2014 | May 15, 2014 |